(Q42963305)

11 November 2017

title

Single-center experience with drug-induced liver injury from India: causes, outcome, prognosis, and predictors of mortality (English)

1 reference

11 November 2017

1 reference

Harshad Devarbhavi

1

1 reference

11 November 2017

Ross Dierkhising

2

1 reference

11 November 2017

Walter K Kremers

3

1 reference

11 November 2017

M S Sandeep

4

1 reference

11 November 2017

Dheeraj Karanth

5

1 reference

11 November 2017

C K Adarsh

6

1 reference

11 November 2017

language of work or name

English

0 references

publication date

20 July 2010

1 reference

The American Journal of Gastroenterology

11 November 2017

published in

1 reference

11 November 2017

volume

105

1 reference

11 November 2017

issue

11

1 reference

11 November 2017

page(s)

2396-2404

1 reference

Drug-related hepatotoxicity

11 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.287

Acute and clinically relevant drug-induced liver injury: a population based case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.287

Drug-induced liver injury: summary of a single topic clinical research conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.287

Drug hepatotoxicity from a regulatory perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.287

Antibiotic therapy: a major cause of drug-induced jaundice in southwest England.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.287

Incidence of drug-induced liver injury in medical inpatients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.287

Incidence of drug-induced hepatic injuries: a French population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.287

Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.287

Outcome and prognostic markers in severe drug-induced liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.287

Liver transplantation for acute liver failure from drug induced liver injury in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.287

Drug-induced liver injury in Japan: An analysis of 1676 cases between 1997 and 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.287

Assessment of 287 Japanese cases of drug induced liver injury by the diagnostic scale of the International Consensus Meeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.287

Early indicators of prognosis in fulminant hepatic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.287

Criteria of drug-induced liver disorders. Report of an international consensus meeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.287

Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.287

Rules and laws of drug hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.287

Adverse reactions to first-line antituberculosis drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.287

Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.287

Clinically significant interactions with drugs used in the treatment of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.287

Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.287

Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.287

Clinical characteristics and prognostic markers in disulfiram-induced liver injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.287

Recognizing drug-induced liver injury: current problems, possible solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.287

Causality assessment in drug-induced hepatotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.287

Under-reporting of adverse drug reactions : a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.287

Outcome of liver transplantation for drug-induced acute liver failure in the United States: analysis of the United Network for Organ Sharing database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.287

MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.287

Herbal medicines in acute viral hepatitis: a ticket for more trouble

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.287

Heavy metal content of ayurvedic herbal medicine products

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2010.287

21 January 2018

Identifiers

DOI

10.1038/AJG.2010.287

1 reference

11 November 2017

1 reference